34820-02-5

Upstream product

• 98-88-4 benzoyl chloride 
• 100-39-0 benzyl bromide 
• 40010-11-5 methyl 3-O-benzyl-β-D-galactopyranoside 
• 1824-94-8 methyl beta-D-galactopyranoside 
• 187458-80-6 methyl 3-O-(4-methoxybenzyl)-β-D-galactopyranoside 
• 187458-82-8 methyl 2,4,6-tri-O-benzoyl-3-O-p-methoxybenzyl-β-D-galactopyranoside 
• 98056-57-6 methyl 2,4,6-tri-O-benzoyl-β-D-galactopyranoside 

Downstream Products

• 126295-06-5 methyl 3-O-<2,2,2-D3>acetyl-2,4,6-tri-O-benzoyl-β-D-galactopyranoside 
• 192223-18-0 methyl 2,3,4-tri-O-benzyl-3-O-(2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl)-β-D-galactopyranoside 
• 1141935-29-6 methyl 3-O-[3,4,6-tri-O-acetyl-2-deoxy-2-(2,2,2-trichlorethoxycarbonylamino)-β-D-glucopyranosyl]-2,4,6-tri-O-benzoyl-β-D-galactopyranoside 
• 1236034-65-3 methyl 3-O-(3,4,6-tri-O-acetyl-2-deoxy-2-trichloroacetamido-β-D-glucopyranosyl)-2,4,6-tri-O-benzoyl-β-D-galactopyranoside 
• 124314-31-4 methyl 2,4,6-tri-O-benzoyl-3-deoxy-3-iodo-β-D-gulopyranoside 
• 30076-92-7 methyl 2,4,6-tri-O-benzoyl-3-deoxy-β-D-xylo-hexopyranoside 
• 98056-63-4 methyl O-(2,4,6-tri-O-benzoyl-β-D-galactopyranosyl)-(1<*>3)-2,4,6-tri-O-benzoyl-β-D-galactopyranoside 
• 7115-19-7 methyl β-D-galactopyranosyl-<1->3>-β-D-galactopyranoside 
• 192223-19-1 2,3,4-tri-O-benzyl-3-O-(2,3,5-tri-O-benzoyl-α-L-arabinofuranosyl)-β-D-galactopyranosyl chloride 
• 124314-32-5 methyl 2,4,6-tri-O-benzoyl-3-O-(imidazol-1-ylthiocarbonyl)-β-D-galactopyranoside 
• 98056-62-3 methyl O-(2,4,6-tri-O-benzoyl-3-O-benzyl-β-D-galactopyranosyl)-(1<*>3)-2,4,6-tri-O-benzoyl-β-D-galactopyranoside 
• 98056-61-2 methyl 2,4,6-tri-O-benzoyl-3-O-(2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl)-D-galactopyranoside 
• 126295-05-4 methyl O-(2-O-<2,2,2-D3>acetyl-3,4,6-tri-O-acetyl-β-D-galacto-pyranosyl)-(1->3)-2,4,6-tri-O-benzoyl-β-D-galactopyranoside 
• 124314-30-3 methyl 2,4,6-tri-O-benzoyl-3-O-(trifluoromethylsulfonyl)-β-D-galactopyranoside 

Relevant academic research and scientific papers

The flexibility of the LeaLex Tumor Associated Antigen central fragment studied by systematic and stochastic searches as well as dynamic simulations

The solution conformational behavior of the Tumor-Associated Carbohydrate Antigen LeaLex central fragment: methyl α-l-fucopyranosyl-(1→4)-2-acetamido-2-deoxy-β-d-glucopyranosyl-(1→3)-β-d-galactopyranoside was studied using three comp

Synthesis of a trisaccharide repeating unit related to arabinogalactan-protein (AGP) polysaccharides

Starting from L-arabinose and methyl β-D-galactopyranoside, methyl 2,3,4-tri-O-benzyl-6-O-[2,4,6-tri-O-benzoyl-3-O-(2,3,5-tri-O-benzoyl-α-L- arabinofuranosyl)-β-D-galactopyranosyl]-β-D-galactopyranoside 10 has been synthesized. Removal of protecting groups gave the methyl glycoside 12 of a trisaccharide representative of a repeating unit of arabinogalactan (AGP) polysaccharides.

Dioxolanylium Ions Derived from Carbohydrates. VI. Rearrangement of Derivatives of α- and β-Galactopyranosides and Their Reaction with Nucleophiles

The position of the equilibrium 2->/-3 for a number of 2-phenyl-1,3-dioxolanylium ions, fused to carbohydrates of the galacto and gulo configuration, has been measured in acetonitrile solution.THe anomeric configuration was found to influence both the position of the equilibrium between the benzoxonium ions and the outcome of the trans-opening of the benzoxonium ions with bromine ion.